Conserving, Distributing and Managing Genetically Modified Mouse Lines by Sperm Cryopreservation

Sperm from C57BL/6 mice are difficult to cryopreserve and recover. Yet, the majority of genetically modified (GM) lines are maintained on this genetic background.Reported here is the development of an easily implemented method that consistently yields fertilization rates of 70+/-5% with this strain. This six-fold increase is achieved by collecting sperm from the vas deferens and epididymis into a cryoprotective medium of 18% raffinose (w/v), 3% skim milk (w/v) and 477 microM monothioglycerol. The sperm suspension is loaded into 0.25 mL French straws and cooled at 37+/-1 degrees C/min before being plunged and then stored in LN(2). Subsequent to storage, the sperm are warmed at 2,232+/-162 degrees C/min and incubated in in vitro fertilization media for an hour prior to the addition of oocyte cumulus masses from superovulated females. Sperm from 735 GM mouse lines on 12 common genetic backgrounds including C57BL/6J, BALB/cJ, 129S1/SvImJ, FVB/NJ and NOD/ShiLtJ were cryopreserved and recovered. C57BL/6J and BALB/cByJ fertilization rates, using frozen sperm, were slightly reduced compared to rates involving fresh sperm; fertilization rates using fresh or frozen sperm were equivalent in all other lines. Developmental capacity of embryos produced using cryopreserved sperm was equivalent, or superior to, cryopreserved IVF-derived embryos.Combined, these results demonstrate the broad applicability of our approach as an economical and efficient option for archiving and distributing mice

Discovery of Porcine microRNAs in Multiple Tissues by a Solexa Deep Sequencing Approach

The domestic pig (Sus scrofa) is an important economic animal for meat production and as a suitable model organism for comparative genomics and biomedical studies. In an effort to gain further identification of miRNAs in the pig, we have applied the Illumina Solexa sequencing technology to carry out an in-depth analysis of the miRNA transcriptome in a pool of equal amounts of RNA from 16 different porcine tissues. From this data set, we identified 437 conserved and 86 candidate novel miRNA/miRNA* in the pig, corresponding to 329 miRNA genes. Compared with all the reported porcine miRNAs, the result showed that 112 conserved and 61 candidate novel porcine miRNA were first reported in this study. Further analysis revealed extensive sequence variations (isomiRs) of porcine miRNAs, including terminal isomiRs at both the 5′ and 3′ ends and nucleotide variants. Read counts of individual porcine miRNA spanned from a few reads to approximately 405541 reads, confirming the different level of expression of porcine miRNAs. Subsequently, the tissue expression patterns of 8 miRNAs were characterized by Northern blotting. The results showed that miR-145, miR-423-5p, miR-320, miR-26a, and miR-191 are ubiquitously expressed in diverse tissues, while miR-92, miR-200a, and miR-375 were selectively enriched and expressed in special tissues. Meanwhile, the expression of 8 novel porcine-specific miRNAs was validated by stem-loop RT-PCR, and one of these was detected by Northern blotting. Using the porcine miRNA array designed according to our Solexa results, 123 miRNAs were detected expression in porcine liver tissues. A total of 58 miRNAs showed differential expression between the Tongcheng (a Chinese indigenous fatty breed) and Large White pig breeds (a lean type pig). Taken together, our results add new information to existing data on porcine miRNAs and should be useful for investigating the biological functions of miRNAs in pig and other species

Family building and the regulation of embryo donation, donor insemination and surrogacy in Australia

The use of assisted reproductive technology (ART) in Australia was initially focused on artificial insemination (AI) with partner or donor sperm to achieve pregnancy. While globally AI has reportedly existed for centuries (Critser 1995), AI and ART in Australia increased significantly following techniques that allowed for the freezing of human sperm and advances in in vitro fertilisation (IVF) (Allan 2017a). In Australia, the first human pregnancy resulting from IVF occurred in Victoria, in 1973, the first child born following IVF was in 1981, and the first child born from egg donation was reported in 1983 (Leeton 2004). At the same time, concern about the social, ethical, and legal questions such practices raised, led to many inquiries to determine whether they were acceptable, to what extent, and to address issues surrounding legal parentage, donation of gametes and embryos. Over time, surrogacy arrangements, which most often involve the use of IVF and may involve the use of donor gametes (eggs or sperm) or embryos, also became the focus of regulation. Tis Chapter provides an overview of Australia’s approach to regulating such practices across its states and territories. It focuses upon eligibility criteria for access to ART, screening of applicants who wish to access ART, access to information about genetic heritage and relations, family limits, and the regulation of surrogacy. While predominantly descriptive in nature the discussion of such regulation highlights the complexity of regulation of ART and surrogacy in Australia, which requires knowledge of multiple jurisdictions’ laws. It also highlights the issues that have been seen in need of regulation, and the regulatory responses that have set boundaries regarding permissible and/or prohibited practices in the respective jurisdictions of Australia and the conditions in which ART and surrogacy may occur